carmot glp 1 Therapeutics starts phase 2 trial for CT-868, a GLP-1/GIP agonist, to treat Type Diabetes Regeneron & Hansoh's GLP-1 Deal
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

























